ViAqua Therapeutics was established in September 2014 to address the growing need for effective, affordable health management of diseases in aquaculture. To date, ViAqua has received investments from The Trendlines Group , Nutreco, VisVires New Protein and the Technion–Israel Institute of Technology, with support from the Israel Innovation Authority.
Vietnam's Tuna Exports in November Fall Short of Expectations Viet Nam
Vietnam's tuna exports in November 2024 failed to sustain the rapid growth momentum seen earlier in the year. The export value for the month reached nearly $82 million, marking an increase of just...
ViAqua Therapeutics Ltd.
Print
